Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture

Journal of Pharmaceutical and Biomedical Analysis

Volumn 30, Issue 4, 2002, Pages 1233-1247

  Jones, Christopher ^a   Lemercinier, Xavier ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Glycoconjugate vaccine; Meningococcal polysaccharides; Neisseria meningitidis; NMR spectroscopy

Indexed keywords

ACETIC ACID DERIVATIVE; BACTERIAL POLYSACCHARIDE; MENINGOCOCCUS VACCINE;

ARTICLE; CATALYSIS; DRUG ACETYLATION; DRUG MANUFACTURE; DRUG STRUCTURE; NEISSERIA MENINGITIDIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

ACETYLATION; BACTERIAL VACCINES; CAPSULES; MAGNETIC RESONANCE SPECTROSCOPY; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; REPRODUCIBILITY OF RESULTS;

EID: 0037038347     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00462-4     Document Type: Article

References (42)

1. Tikhomirov E., Santamaria M., Esteves K. Wld. Hlth. Statist. Quart. 50:1997;170-177.
2. Lepow M.L. Plotkin S.A., Mortimer E.A., Vaccines. 1994;505-515 WB Saunders and Co, Philadelphia.
3. Jennings H.J. Current topics in microbiology and immunology. Jann K., Jann B., Bacterial Capsules. 150:1990;97-127 Springer, Berlin.
4. Morley S.L., Pollard A.J. Vaccine. 20:2002;666-687.
5. Racoosin J.A., Whitney C.G., Conover C.S., Diaz P.S. JAMA. 280:1998;2094-2098.
6. Communicable Disease Report 10 (2000) 169. Weekly Epidemiological Record 76 (2001) 141-148. Weekly Epidemiological Record 76 (2001) 213-216.
7. Ramsey M.E., Collins M., Rush M., Kaczmarski E.B. Eurosurveillance. 2:1997;74-76.
8. Ramsay M.E., Andrews N., Kaczmarski E.B., Miller E. Lancet. 357:2001;195-196.
9. Borrow R., Fox A.J., Richmond P.C., Clark S., Sadler F., Findlow J., Morris R., Begg N.T., Cartwright K.A. Epidemiol. Infect. 124:2000;427-432.
10. Campagne G., Garba A., Fabre P., et al. Pediatr. Infect. Dis. J. 19:2000;144-150.
11. Lindberg A.A. Vaccine. 17:1999;S28-36.
12. Pon R.A., Lussier M., Yang Q.L., Jennings H.J. J. Exp. Med. 185:1997;1929-1938.
13. Jennings H.J., Roy R., Gamian A. J. Immunol. 137:1986;1708-1713.
14. Jennings H.J., Gamian A., Michon F., Ashton F.E. J. Immunol. 142:1989;3585-3591.
15. Ashton F.E., Ryan J.A., Michon F., Jennings H.J. Microb. Pathog. 6:1989;455-458.
16. European Pharmacopoeia, Third Ed., 1997, pp. 1155-1157.
17. C. Jones, X. Lemercinier, in: Biologicals Beyond 2000: Challenges for Quality Standards in an Evolving Field, Pharmeuropa, 2000, pp. 119-129.
18. Lemercinier X., Jones C. Biologicals. 28:2000;75-83.
19. Abeygunawadana C., Williams T.C., Sumner J.S., Hennessey J.P. Jr. Anal. Biochem. 279:2000;226-240.
20. Lemercinier X., Martinez-Cabrera I., Jones C. Biologicals. 28:2000;17-24.
21. Lemercinier X., Jones C. Carbohydr. Res. 296:1996;83-96.
22. Ravenscroft N, in: Biologicals Beyond 2000: Challenges for Quality Standards in an Evolving Field, Pharmeuropa, 2000, pp. 119-129.
23. Egan W., Schneerson R., Werner K., Zon G. J. Am. Chem. Soc. 104:1982;2898-2910.
24. Jones C., Lemercinier X., Crane D.T., Gee C.K., Austin S. Dev. Biol. 103:2000;121-136.
25. Lifely M.R., Gilbert A.S., Moreno C. Carbohydr. Res. 134:1984;229-243.
26. Lifely M.R., Gilbert A.S., Moreno C. Carbohydr. Res. 194:1981;193-200.
27. Jennings H.J., Bhattacharjee A.K., Bundle D.R., Kenny C.P., Martin A., Smith I.C.P. J. Infect. Dis. 136:1977;S78-83.
28. Bhattacharjee A.K., Jennings H.J., Kenny C.P., Martin A., Smith I.C.P. Can. J. Biochem. 54:1976;1-8.
29. Bundle D.R., Smith I.C.P., Jennings H.J. J. Biol. Chem. 249:1974;2275-2281.
30. Bhattacharjee A.K., Jennings H.J., Kenny C.P., Martin A., Smith I.C.P. J. Biol. Chem. 250:1975;1926-1932.
31. Yamasaki R. Biochem. Biophys. Res. Commun. 154:1988;159-164.
32. Yamasaki R., Bacon B. Biochemistry. 30:1991;851-857.
33. Michon F., Brisson J.R., Jennings H.J. Biochemistry. 26:1987;8399-8405.
34. Steinhoff M.C., Lewin E.B., Gotschlich E.C., Robbins J.B. Infect. Immun. 34:1981;144-146.
35. Vodopija I., Baklaic Z., Hauser P., Roelants P., Andre F.E. Infect. Immun. 42:1983;599-604.
36. Michon F., Huang C.-H., Farley E.K., Hronowski D.J., Fusco P.C. Dev. Biol. Standard. 103:2000;151-160.
37. Richmond P., Goldblatt D., Fusco P.C., Fusco J.D.S., Heron I., Clark S., Borrow R., Michon F. Vaccine. 18:1999;641-646.
38. S.H. Doares, J.L. Cowell, Abstracts of the 222nd National Meeting of the American Chemical Society, Chicago, 26-30 (August) (2001).
39. Berry D.S., Lynn F., Lee C.-H., Frasch C.E., Bash M.C. Infect. Immun. 70:2002;3707-3713.
40. Longsworth E., Fernstein P., Mininni T.L., Vogel U., Claus H., Gray S., Kaczmarski E., Borrow R. FEMS Immun. Med. Microbiol. 32:2002;119-123.
41. Wishart D.S., Bigam C.G., Yao J., Abildgaard F., Dyson H.J., Oldfield E., Markley J.L., Sykes B.D. J. Biomol. NMR. 6:1995;135-140.
42. D'Ambra A.J., Baugher J.E., Concammon P.E., Pon R.A., Michon F. Anal. Biochem. 250:1997;228-236.